跳至主要内容
临床试验/ISRCTN45716767
ISRCTN45716767已完成未知

A randomised, double-blinded, multicentre, parallel group study comparing a remifentanil-regimen with a fentanyl-regimen for analgesia in mechanically ventilated patients

Charite - University Medicine Berlin (Charite - Universitatsmedizin Berlin) (Germany)0 个研究点目标入组 160 人开始时间: 2007年10月3日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
160

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Need for Intensive Care Unit (ICU) treatment because of at least one severe illness
  • 2. Expected mechanical ventilation duration greater than 24 hours
  • 3. Present mechanical ventilation duration less than 48 hours
  • 4. Aged greater than 18 years

排除标准

  • 1. Expected ICU therapy less than 24 hours
  • 2. Present mechanical ventilation duration greater than 48 hours
  • 3. Expected ventilation duration greater than 24 hours
  • 4. Pregnancy
  • 5. Expected limited cerebral or neurological ability caused by:
  • 5.1. Hypoxic brain damage
  • 5.2. Severe traumatic brain injury
  • 5.3. Cranial mass bleeding
  • 5.4. Dementia
  • 5.5. Parkinson's disease
  • 5.6. Motor Neuron Disease
  • 6. Myasthenia gravis
  • 7. Need for chronical artificial ventilation
  • 8. Chronic-pain patients (World Health Organization [WHO] grade III)
  • 9. Patients with spinal anaesthesia
  • 10. Peridural anaesthesia with opioids
  • 11. Patients with severe illnesses (American Society of Anaesthesiologists [ASA] grade V)
  • 12. Patients who took part on other studies the last 30 days
  • 13. No permission for study treatment

研究者

发起方
Charite - University Medicine Berlin (Charite - Universitatsmedizin Berlin) (Germany)

相似试验

进行中(未招募)
不适用
A randomised, double-blinded, multicenter, parallel group study comparing a remifentanil-regimen with a fentanyl-regimen for analgesia in mechanically ventilated patientsmaschinell ventielierte Patienten auf der Intensivstation
EUCTR2005-001907-21-DEKlinik für Anästhesiologie und operative Intensivmedizin, Charité – Universitätsmedizin Berlin160
招募中
不适用
A multicenter, double-blinded, randomized, parallel group and placebo-controlled clinical study of the efficacy and safety of Fuzheng Jiedu granules in the treatment of COVID-19COVID-19
ITMCTR2200006369The Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Traditional Chinese Medicine)
招募中
不适用
HIPER-500
KCT0002734Samsung Medical Center120
进行中(未招募)
不适用
The aim of this clinical study is to show efficacy and safety of cells in patients suffering from stress urinary incontinence and to show superiority of cells in female patients with stress urinary incontinence over placebo.Stress urinary incontinence (SUI) of moderate severity (Grade 2 and Grade 3) in female patientsMedDRA version: 17.0Level: PTClassification code 10066218Term: Stress urinary incontinenceSystem Organ Class: 10038359 - Renal and urinary disorders
EUCTR2010-021871-10-ATInnovacell Biotechnologie AG - Life Science Center Innsbruck372
进行中(未招募)
不适用
The aim of this clinical study is to show efficacy and safety of cells in patients suffering from stress urinary incontinence and to show superiority of cells in female patients with stress urinary incontinence over placebo.Stress urinary incontinence (SUI) of moderate severity (Grade 2 and Grade 3) in female patientsMedDRA version: 14.1Level: PTClassification code 10066218Term: Stress urinary incontinenceSystem Organ Class: 10038359 - Renal and urinary disorders
EUCTR2010-021871-10-BGInnovacell Biotechnologie AG - Life Science Center Innsbruck372